EMEA-001262-PIP01-12-M03
Key facts
Active substance |
Dobutamine
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0182/2017
|
PIP number |
EMEA-001262-PIP01-12-M03
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of neonatal circulatory failure
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Proveca Limited
Tel. +44 7913048665 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|